Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate

Virology

Volumn 227, Issue 1, 1997, Pages 96-102

  Mason, P W ^a   Piccone, M E ^a,c   McKenna, T St C ^b   Chinsangaram, J ^a   Grubman, M J ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b U S DEPARTMENT OF AGRICULTURE   (United States)

^c INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CATTLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; IMMUNIZATION; NONHUMAN; PRIORITY JOURNAL; VIRUS ATTENUATION; VIRUS NEUTRALIZATION;

ANIMALIA; BOS TAURUS; BOVINAE; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 0031555642     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8309     Document Type: Article

References (33)

1. Bachrach, H. L. (1968). Foot-and-mouth disease. Annu. Rev. Microbiol. 22, 201-244.
2. Bachrach, H. L. (1978). Foot-and-mouth disease: World-wide impact and control measures. In "Viruses and Environment" (E. Kurstak and K. Maramorosch, Eds.), pp. 299-310. Academic Press, New York.
3. Bahnemann, H. G. (1990). Inactivation of virus antigens for vaccine preparation with particular reference to the application of binary ethylenemine. Vaccine 8, 75-88.
4. Beck, E., and Strohmaier, K. (1987). Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61, 1621-1629.
5. Brooksby, J. B. (1982). Portraits of viruses: Foot-and-mouth disease virus. Intervirology 18, 1-23.
6. Brown, C. C., Piccone, M. E., Mason, P. W., McKenna, T. St.-C., and Grubman, M. J. (1996). Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in bovines. J. Virol. 70, 5638-5641.
7. Brown, F. (1992). New approaches to vaccination against foot-and-mouth disease. Vaccine 10, 1022-1026.
8. Brown, F., Newman, J., Stott, J., Porter, A., Frisby, D., Newton, C., Carey, N., and Fellner, P. (1974). Poly(C) in animal viral RNAs. Nature 251, 342-344.
9. Costa Giomi, M. P., Gomes, I., Tiraboschi, B., Auge de Mello, P., Bergmann, I. E., Schodeller, E. A., and La Torre, J. L. (1988). Heterogeneity of the polyribocytidilic acid tract in aphthovirus: Changes in the size of poly(C) of viruses recovered from persistently infected cattle. Virology 162, 58-64.
10. Cottral, G. E., Patty, R. E., Gailiunas, P., and Scott, F. W. (1965). Sensitivity of cell cultures, cattle, mice, and guinea-pigs for detection of nineteen foot-and-mouth disease viruses. Bull. Off. Int. Epiz. 63, 1607-1625.
11. Devaney, M. A., Vakharia, V. N., Lloyd, R. E., Ehrenfeld, E., and Grubman, M. J. (1988). Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62, 4407-4409.
12. Donaldson, A. I., and Doel, T. R. (1992). Foot and mouth disease. "Office International des Epizooties Manual of Standards for Diagnostic Tests and Vaccines" (Standards Commission, Eds.), 2nd ed., pp. 1-12. Office International des Epizooties, Paris.
13. Duke, G. M., and Palmenberg, A. C. (1989). Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts. J. Virol. 63, 1822-1826.
14. Escarmis, C., Toja, M., Medina, M., and Domingo, E. (1992). Modification of the 5′ untranslated region of foot-and-mouth disease virus after prolonged persistence in cell culture. Virus Res. 26, 113-125.
15. Etchison, D., Milburn, S. C., Edery, I., Sonenberg, N., and Hershey, J. W. B. (1982). Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257, 14806-14810.
16. Gorbalenya, A. E., Koonin, E. V., and Lai, M. M.-C. (1991). Putative papain-related thiol proteases of positive-strand RNA viruses: Identification of rubi-and aphthovirus proteases and delineation of a novel conserved domain associated with proteases of rubi-, α-, and coronaviruses. FEBS Lett. 288, 201-205.
17. Harris, T. J. R., and Brown, F. (1977). Biochemical analysis of a virulent and an avirulent foot-and-mouth disease virus. J. Gen. Virol. 34, 87-105.
18. Hahn, H., and Palmenberg, A. C. (1995). Encephalomyocarditis viruses with short poly(C) tracts are more virulent than their mengovirus counterparts. J. Virol. 69, 2696-2699.
19. Israel, B. A., Herber, R., Gao, Y., and Letchworth, G. J. (1992). Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle. Virology 188, 258-264.
20. King, A. M. Q., Underwood, B. O., McCahon, D., Newman, J. W. I., and Brown, F. (1981). Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK. Nature 293, 479-480.
21. Kirchweger, R., Ziegler, E., Lamphear, B. J., Waters, D., Liebig, H.-D., Sommergruber, W., Sobrino, F., Hohenadl, C., Blass, D., Rhoads, R. E., and Skern, T. (1994). Foot-and-mouth disease virus leader proteinase: Purification of the Lb form and determination of its cleavage site on elF-4γ. J. Virol. 68, 5677-5684.
22. Kleina, L. G., and Grubman, M. J. (1992). Antiviral effects of athiol protease inhibitor on foot-and-mouth disease virus. J. Virol. 66, 7168-7175.
23. McCauley, E. H., Aulaqi, N. A., New, J. C., Sundquist, W. B., and Miller, W. M. (1979). "A Study of the Potential Economic Impact of Foot-and-Mouth Disease in the United States." U.S. Government Printing Office, Washington, DC.
24. McKenna, T. S. C., Lubroth, J., Rieder, E., Baxt, B., and Mason, P. W. (1995). Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69, 5787-5790.
25. Medina, M., Domingo, E., Brangwyn, J. K., and Belsham, B. J. (1993). The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology 194, 355-359.
26. Osorio, J. E., Hubbard, G. B., Soike, K. F., Girard, M., van der Werf, S., Moulin, J.-C., and Palmenberg, A. C. (1996). Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered mengo virus. Vaccine 14, 155-161.
27. Piccone, M. E., Reder, E., Mason, P. W., and Grubman, M. J. (1995a). The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69, 5376-5382.
28. Piccone, M. E., Zellner, M., Kumosinski, T. F., Mason, P. W., and Grubman, M. J. (1995b). Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J. Virol. 69, 4950-4956.
29. Rieder, E., Bunch, T., Brown, F., and Mason, P. W. (1993). Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67, 5139-5145.
30. Roberts, P. J., and Belsham, G. (1995). Identification of the critical amino acids within the foot-and-mouth disease virus leader protein, a cysteine protease. Virology 213, 140-146.
31. Salt, J. S. (1993). The carrier state in foot-and-mouth disease - An immunological review. Br. Vet. J. 149, 207-223.
32. Strebel, K., and Beck, E. (1986). A second protease of foot-and-mouth disease virus. J. Virol. 58, 893-899.
33. Zibert, A., Maass, G., Strebel, K., Falk, M. M., and Beck, E. (1990). Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J. Virol. 64, 2467-2473.